---

Obesity Hypoventilation Syndrome (OHS) - Complete 10 Mark Answer

---

Definition

1. Obesity - BMI ≥ 30 kg/m²
2. Daytime hypercapnia - awake PaCO₂ ≥ 45 mmHg
3. Sleep-disordered breathing - in the absence of other causes of chronic alveolar hypoventilation (e.g., COPD, neuromuscular disease, chest wall deformity, hypothyroidism, central hypoventilation)

• Fishman's Pulmonary Diseases and Disorders, 2-Volume Set
• Harrison's Principles of Internal Medicine 22E (2025)

---

Epidemiology

• OSA is present in 90% of OHS patients; ~70% have severe OSA (AHI >30 events/h)
• OHS often remains undiagnosed - patients have increased healthcare utilization up to 5 years before diagnosis

---

Pathophysiology

1. Abnormal Respiratory Mechanics (Mechanical Load)

• Excess adipose tissue on thorax and abdomen reduces chest wall compliance and end-expiratory lung volume
• Increases elastic and resistive work of breathing
• Cranial displacement of the diaphragm (especially supine) impairs respiratory pump efficiency
• Premature airway closure causes atelectasis, V/Q mismatch, increased A-a gradient, and hypoxemia
• CO₂ production is 2-3x normal in morbid obesity - requires doubled alveolar ventilation to maintain eucapnia

2. Sleep-Disordered Breathing

• Recurrent apneas/hypopneas cause episodic CO₂ accumulation during sleep
• Retained bicarbonate (renal compensation) blunts the hypercapnic ventilatory response (HCVR)
• Progressive CO₂ retention extends from sleep to wakefulness
• The remaining 10% of OHS patients (without OSA) show pure non-obstructive sleep hypoventilation with PaCO₂ rising >10 mmHg above wakefulness

3. Blunted Central Ventilatory Drive

• Impaired chemosensitivity to both hypercapnia and hypoxemia
• Key role of leptin resistance: leptin (produced by adipose tissue) normally stimulates ventilation via hypothalamic receptors; in OHS, central leptin resistance blunts this drive
• This blunting is likely a consequence of chronic hypoventilation rather than a primary cause - it often reverses with PAP treatment even without weight loss
• Eucapnic obese subjects show greater diaphragmatic electrical activity response to CO₂ than hypercapnic subjects

Consequences of Chronic Hypercapnia

• Polycythemia
• Pulmonary hypertension
• Cor pulmonale
• Right ventricular failure

---

Clinical Features

• Excessive daytime somnolence (Epworth Sleepiness Scale typically elevated)
• Morning headaches (CO₂ retention)
• Dyspnea on exertion, orthopnea
• Loud snoring, witnessed apneas
• Cognitive impairment, fatigue, depression

• Morbid obesity (BMI often >35-40 kg/m²)
• Cyanosis, plethora
• Edema (cor pulmonale)
• Loud P2, raised JVP
• Features of right heart failure

---

Investigations

Blood Gas and Biochemistry

Pulmonary Function Tests

• Reduced TLC, FRC, ERV, VC
• Reduced respiratory system compliance
• Possible mild obstructive or restrictive pattern

Sleep Study (Polysomnography)

• AHI - determines OSA severity
• Pulse oximetry - nocturnal desaturation
• End-tidal CO₂ (ETCO₂) or transcutaneous CO₂ monitoring
• Sleep-related hypoventilation: PaCO₂ (or surrogate) rises >10 mmHg during sleep to >50 mmHg for >10 minutes

Imaging

• CXR: cardiomegaly, plethoric lung fields
• ECG: RVH, RAD, P pulmonale
• Echocardiogram: pulmonary hypertension, RV dilation, LV diastolic dysfunction

---

Treatment

1. Weight Loss

• Substantial weight loss (20-25% of actual body weight) alone can normalize PaCO₂
• Bariatric surgery is the most effective method; difficult to achieve and sustain otherwise
• First-line long-term strategy but rarely achieves rapid reversal

2. Positive Airway Pressure (PAP) Therapy - Stepwise Algorithm

OHS Diagnosed
      |
      ▼
Severe OSA present (AHI >30)?
      |
   YES → Start CPAP first (treats both OSA and hypoventilation in ~80% of OHS+OSA)
      |
      ▼
Re-evaluate in 4-8 weeks
      |
Hypercapnia persists despite good CPAP adherence?
      |
   YES → Upgrade to BiPAP-S (Spontaneous mode)
      |
      ▼
Still inadequate (low minute ventilation, ongoing CO₂ elevation)?
      |
   YES → BiPAP-ST (Spontaneous-Timed / backup rate) or AVAPS

• If no severe OSA (low-AHI OHS): Start directly with BiPAP-ST or VAPS mode
• Acute decompensated OHS: Start BiPAP-ST or NIV immediately during hospitalization

---

VENTILATOR SETTINGS IN OHS (High-Yield for MD Exams)

A. CPAP (Continuous Positive Airway Pressure)

• Indication: OHS with severe OSA (AHI >30/hr) as first-line therapy
• Starting pressure: Typically 8-15 cmH₂O, titrated by PSG or auto-titration
• Goal: Eliminate obstructive events, allow CO₂ to normalize
• Success: Eliminates both OSA and OHS in ~80% of patients with predominant obstructive etiology
• Failure criteria: Persistent hypercapnia (PaCO₂ still elevated or serum HCO₃ not normalizing after 4-8 weeks of adherent CPAP use)

B. BiPAP-S (Bilevel PAP - Spontaneous Mode)

• Indication: Failed CPAP (obstructive events persist or maximum CPAP pressure 20 cmH₂O reached); poor CPAP tolerance
• Settings:
  • IPAP: 12-20 cmH₂O (higher than EPAP by at least 4-6 cmH₂O to generate adequate pressure support/tidal volume)
  • EPAP: 4-10 cmH₂O (titrated to abolish obstructive events and PEEP effect)
  • No backup rate in spontaneous mode
• Note: Only suitable when respiratory drive is adequate

C. BiPAP-ST (Bilevel PAP - Spontaneous/Timed Mode) - Most Important for OHS

• Indication:
  • OHS without severe OSA
  • Failed BiPAP-S (reduced minute ventilation)
  • Acute decompensated OHS
  • Hypercapnia persisting despite CPAP adherence
• Settings:

• Key principle: Strategies that increase inhalation time (longer rise time, longer Ti, lower cycle sensitivity) favor larger tidal volumes and improved gas exchange
• The backup rate ensures ventilation during periods of reduced or absent spontaneous effort

D. AVAPS / VAPS (Average Volume-Assured Pressure Support)

• Mode: Hybrid adaptive algorithm - automatically adjusts IPAP/PS between a minimum and maximum to achieve a preset target tidal volume or minute ventilation
• Devices: AVAPS (Philips); iVAPS (ResMed)
• Target tidal volume: 8-10 mL/kg ideal body weight (NOT actual body weight - critical point for OHS)
  • Use ideal body weight to avoid over-ventilation
• Settings:

• Advantage: Automatically compensates for fluctuating respiratory mechanics (e.g., REM sleep, positional changes, disease progression), prevents hypoventilation from leaks
• Caveats: Overestimation of exhaled Vt due to mask leak can cause algorithm-induced hypoventilation; higher cost; not superior to BiPAP-ST in most RCTs (minimal additional PaCO₂ reduction of ~2 mmHg); may impair subjective sleep quality

E. Summary of Mode Selection

---

Supplemental Oxygen

• Used adjunctively when hypoxemia persists despite adequate PAP therapy
• Avoid oxygen alone without PAP - it can worsen hypercapnia by blunting hypoxic drive
• Added as supplemental O₂ bled into circuit when SpO₂ targets not met on NIV alone

---

Monitoring Response to Treatment

• Serum bicarbonate normalization - within weeks of effective PAP
• ABG normalization (PaCO₂ to <45 mmHg)
• Epworth Sleepiness Scale improvement
• Polysomnography with CO₂ monitoring: formal PSG and ventilator titration recommended within 3 months of discharge (ATS recommendation)
• Surrogate CO₂ monitoring: ETCO₂ or transcutaneous CO₂ (PtcCO₂) used during titration night

---

Prognosis and Mortality

• 2-year all-cause mortality in hospitalized OHS patients: ~23% (vs. 9% in simple obesity)
• 1-year mortality after acute-on-chronic hypercapnic respiratory failure in OHS: ~18%
• Untreated OHS is associated with significantly higher mortality than BMI-matched OSA
• Effective PAP therapy and weight loss improve cardiovascular outcomes and survival
• Recent meta-analysis (PMID: 40605318, 2025) confirms PAP therapy reduces pulmonary artery pressure in OHS with pulmonary hypertension

---

Key Exam Points to Remember

1. Diagnostic triad: BMI ≥30 + PaCO₂ >45 + sleep-disordered breathing (after excluding other causes)
2. Screening: Serum HCO₃ < 27 virtually excludes OHS; ≥27 needs ABG confirmation
3. 90% have OSA; CPAP resolves OHS in 80% of these - try CPAP first
4. AVAPS target Vt = 8-10 mL/kg IDEAL body weight (not actual)
5. Backup rate in BiPAP-ST = ~2 breaths below spontaneous rate (typically 10-14/min)
6. Leptin resistance is the key endocrine mechanism of blunted drive
7. Never give O₂ alone - it worsens hypercapnia by removing hypoxic drive
8. Acute decompensated OHS: start NIV in hospital and continue at discharge
9. Formal PSG + ventilator titration within 3 months of hospital discharge (ATS guideline)
10. Weight loss of 20-25% normalizes PaCO₂ - bariatric surgery is most reliable method

---